Maurizio Cantore

Summary

Country: Italy

Publications

  1. doi request reprint Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma
    M Cantore
    Oncological Department, Carrara Hospital, Carrara, Italy
    Br J Surg 99:1083-8. 2012
  2. ncbi request reprint Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study
    Andrea Mambrini
    Department of Oncology and 3Radiology, Carrara City Hospital, Carrara, Italy
    Anticancer Res 27:3009-13. 2007
  3. doi request reprint Chemotherapy in the last 30 days of life of advanced cancer patients
    Paola Pacetti
    Oncological Department, Azienda USL1 di Massa Carrara, Carrara, Italy
    Support Care Cancer 23:3277-80. 2015

Detail Information

Publications3

  1. doi request reprint Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma
    M Cantore
    Oncological Department, Carrara Hospital, Carrara, Italy
    Br J Surg 99:1083-8. 2012
    ..Radiofrequency ablation (RFA) is an emerging treatment for patients with locally advanced pancreatic carcinoma, and can be combined with radiochemotherapy and intra-arterial plus systemic chemotherapy...
  2. ncbi request reprint Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study
    Andrea Mambrini
    Department of Oncology and 3Radiology, Carrara City Hospital, Carrara, Italy
    Anticancer Res 27:3009-13. 2007
    ..The aim of the present study was to evaluate the activity of hepatic intra-arterial infusion of epirubicin and cisplatin combined with oral capecitabine, in patients with unresectable biliary carcinomas...
  3. doi request reprint Chemotherapy in the last 30 days of life of advanced cancer patients
    Paola Pacetti
    Oncological Department, Azienda USL1 di Massa Carrara, Carrara, Italy
    Support Care Cancer 23:3277-80. 2015
    ..Chemotherapy near the end of life is an issue frequently discussed nowadays, but literature is generally poor. We analyzed patients with cancer who received chemotherapy in their last month of life...